<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anuh Pharma Ltd has confirmed to BSE and NSE that it does not qualify as a 'Large Corporate' under SEBI's regulatory framework. The company meets only one of three required conditions—having its equity shares listed on BSE and NSE. It does not meet the other two conditions: outstanding long-term borrowings of Rs. 1,000 crore or more, and possessing a credit rating of AA/AA+/AAA. As a result, the company is not required to file the Initial Disclosure for FY 2026-27 under SEBI Circular dated October 19, 2023.
This is a routine compliance filing with no direct impact on shareholders or stock price. The company is simply clarifying its regulatory status, indicating it falls below the thresholds that would trigger additional disclosure obligations.